Guided Therapeutics (GTHP) Other Operating Expenses (2010 - 2026)

Guided Therapeutics has disclosed Other Operating Expenses across 17 years of filings, most recently posting $21000.0 for Q2 2026.

• In Q2 2026, Other Operating Expenses fell 58.82% year-over-year to $21000.0; the TTM figure through Jun 2026 stood at -$128000.0 (down 147.58% YoY), while the FY2025 annual figure was $169000.0, down 41.11% from the prior year.
• Other Operating Expenses came in at $21000.0 for Q2 2026 at Guided Therapeutics, up from -$194000.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $86000.0 in Q4 2023 to a low of -$194000.0 in Q1 2026.
• Average Other Operating Expenses over 5 years is $30777.8, with a median of $45000.0 recorded in 2022.
• Year-over-year, Other Operating Expenses soared 6200.0% in 2023 and slumped 365.75% in 2026.
• Over 5 years, Other Operating Expenses stood at $39000.0 in 2022, then surged by 120.51% to $86000.0 in 2023, then retreated by 19.77% to $69000.0 in 2024, then plunged by 66.67% to $23000.0 in 2025, then dropped by 8.7% to $21000.0 in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $21000.0 in Q2 2026, -$194000.0 in Q1 2026, and $23000.0 in Q4 2025.